APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nifedipine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nifedipine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchNifedipine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nifedipine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Nifedipine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nifedipine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Nifedipine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Nifedipine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nifedipine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nifedipine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nifedipine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nifedipine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nifedipine include Actavis, Bayer, Honglin Pharmaceutical, Huanghai, Pfizer, Lifeon Pharmaceutical, Teva, Simcere and Shyndec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nifedipine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nifedipine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nifedipine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nifedipine market size, projected growth trends, production technologies, key applications, and end-use industries.

Nifedipine Segment by Company

Actavis

Bayer

Honglin Pharmaceutical

Huanghai

Pfizer

Lifeon Pharmaceutical

Teva

Simcere

Shyndec

Yabao

ApicHope

EASEHEAL Pharmaceutical

Nifedipine Segment by Type

Nifedipine Controlled Release Tablets

Nifedipine Extended Action Tablets

Nifedipine Segment by Application

Hypertension

Heart Disease

Other

Nifedipine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nifedipine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nifedipine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nifedipine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nifedipine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nifedipine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nifedipine Industry Trends Table 2. Nifedipine Industry Drivers Table 3. Nifedipine Industry Opportunities and Challenges Table 4. Nifedipine Industry Restraints Table 5. Global Nifedipine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nifedipine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nifedipine Sales by Manufacturers (tons) & (2021-2026) Table 8. Global Nifedipine Sales Market Share by Manufacturers Table 9. Global Nifedipine Average Sales Price (US$/kg) of Manufacturers (2021-2026) Table 10. Global Nifedipine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nifedipine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nifedipine Manufacturers, Product Type & Application Table 13. Global Nifedipine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nifedipine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Nifedipine Controlled Release Tablets Table 17. Major Manufacturers of Nifedipine Extended Action Tablets Table 18. Global Nifedipine Sales by Type 2021 VS 2025 VS 2032 (tons) Table 19. Global Nifedipine Sales by Type (2021-2026) & (tons) Table 20. Global Nifedipine Sales by Type (2027-2032) & (tons) Table 21. Global Nifedipine Sales Market Share by Type (2021-2026) Table 22. Global Nifedipine Sales Market Share by Type (2027-2032) Table 23. Global Nifedipine Revenue by Type 2021 VS 2025 VS 2032 (tons) Table 24. Global Nifedipine Revenue by Type (2021-2026) & (tons) Table 25. Global Nifedipine Revenue by Type (2027-2032) & (tons) Table 26. Global Nifedipine Revenue Market Share by Type (2021-2026) Table 27. Global Nifedipine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hypertension Table 29. Major Manufacturers of Heart Disease Table 30. Major Manufacturers of Other Table 31. Global Nifedipine Sales by Application 2021 VS 2025 VS 2032 (tons) Table 32. Global Nifedipine Sales by Application (2021-2026) & (tons) Table 33. Global Nifedipine Sales by Application (2027-2032) & (tons) Table 34. Global Nifedipine Sales Market Share by Application (2021-2026) Table 35. Global Nifedipine Sales Market Share by Application (2027-2032) Table 36. Global Nifedipine Revenue by Application 2021 VS 2025 VS 2032 (tons) Table 37. Global Nifedipine Revenue by Application (2021-2026) & (tons) Table 38. Global Nifedipine Revenue by Application (2027-2032) & (tons) Table 39. Global Nifedipine Revenue Market Share by Application (2021-2026) Table 40. Global Nifedipine Revenue Market Share by Application (2027-2032) Table 41. Global Nifedipine Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 42. Global Nifedipine Sales by Region (2021-2026) & (tons) Table 43. Global Nifedipine Sales Market Share by Region (2021-2026) Table 44. Global Nifedipine Sales Forecasted by Region (2027-2032) & (tons) Table 45. Global Nifedipine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Nifedipine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 47. North America Nifedipine Sales by Country (2021-2026) & (tons) Table 48. North America Nifedipine Sales by Country (2027-2032) & (tons) Table 49. Europe Nifedipine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 50. Europe Nifedipine Sales by Country (2021-2026) & (tons) Table 51. Europe Nifedipine Sales by Country (2027-2032) & (tons) Table 52. Asia Pacific Nifedipine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 53. Asia Pacific Nifedipine Sales by Country (2021-2026) & (tons) Table 54. Asia Pacific Nifedipine Sales by Country (2027-2032) & (tons) Table 55. South America, Middle East and Africa Nifedipine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 56. South America, Middle East and Africa Nifedipine Sales by Country (2021-2026) & (tons) Table 57. South America, Middle East and Africa Nifedipine Sales by Country (2027-2032) & (tons) Table 58. Global Nifedipine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Nifedipine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Nifedipine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Nifedipine Revenue Market Share by Region (2021-2026) Table 62. Global Nifedipine Revenue Market Share by Region (2027-2032) Table 63. Actavis Company Information Table 64. Actavis Business Overview Table 65. Actavis Nifedipine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Actavis Nifedipine Product Portfolio Table 67. Actavis Recent Development Table 68. Bayer Company Information Table 69. Bayer Business Overview Table 70. Bayer Nifedipine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bayer Nifedipine Product Portfolio Table 72. Bayer Recent Development Table 73. Honglin Pharmaceutical Company Information Table 74. Honglin Pharmaceutical Business Overview Table 75. Honglin Pharmaceutical Nifedipine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Honglin Pharmaceutical Nifedipine Product Portfolio Table 77. Honglin Pharmaceutical Recent Development Table 78. Huanghai Company Information Table 79. Huanghai Business Overview Table 80. Huanghai Nifedipine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Huanghai Nifedipine Product Portfolio Table 82. Huanghai Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Nifedipine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pfizer Nifedipine Product Portfolio Table 87. Pfizer Recent Development Table 88. Lifeon Pharmaceutical Company Information Table 89. Lifeon Pharmaceutical Business Overview Table 90. Lifeon Pharmaceutical Nifedipine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Lifeon Pharmaceutical Nifedipine Product Portfolio Table 92. Lifeon Pharmaceutical Recent Development Table 93. Teva Company Information Table 94. Teva Business Overview Table 95. Teva Nifedipine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Teva Nifedipine Product Portfolio Table 97. Teva Recent Development Table 98. Simcere Company Information Table 99. Simcere Business Overview Table 100. Simcere Nifedipine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Simcere Nifedipine Product Portfolio Table 102. Simcere Recent Development Table 103. Shyndec Company Information Table 104. Shyndec Business Overview Table 105. Shyndec Nifedipine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Shyndec Nifedipine Product Portfolio Table 107. Shyndec Recent Development Table 108. Yabao Company Information Table 109. Yabao Business Overview Table 110. Yabao Nifedipine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Yabao Nifedipine Product Portfolio Table 112. Yabao Recent Development Table 113. ApicHope Company Information Table 114. ApicHope Business Overview Table 115. ApicHope Nifedipine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. ApicHope Nifedipine Product Portfolio Table 117. ApicHope Recent Development Table 118. EASEHEAL Pharmaceutical Company Information Table 119. EASEHEAL Pharmaceutical Business Overview Table 120. EASEHEAL Pharmaceutical Nifedipine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. EASEHEAL Pharmaceutical Nifedipine Product Portfolio Table 122. EASEHEAL Pharmaceutical Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Nifedipine Distributors List Table 126. Nifedipine Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Nifedipine Product Image Figure 2. Global Nifedipine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nifedipine Market Size (2021-2032) & (US$ Million) Figure 4. Global Nifedipine Sales (2021-2032) & (tons) Figure 5. Global Nifedipine Average Price (US$/kg) & (2021-2032) Figure 6. Global Top 5 and 10 Nifedipine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Nifedipine Controlled Release Tablets Image Figure 9. Nifedipine Extended Action Tablets Image Figure 10. Global Nifedipine Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 11. Global Nifedipine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Nifedipine Sales Market Share by Type (2021-2032) Figure 13. Global Nifedipine Revenue by Type (2021 VS 2025 VS 2032) & (tons) Figure 14. Global Nifedipine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Nifedipine Revenue Market Share by Type (2021-2032) Figure 16. Hypertension Image Figure 17. Heart Disease Image Figure 18. Other Image Figure 19. Global Nifedipine Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 20. Global Nifedipine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Nifedipine Sales Market Share by Application (2021-2032) Figure 22. Global Nifedipine Revenue by Application (2021 VS 2025 VS 2032) & (tons) Figure 23. Global Nifedipine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Nifedipine Revenue Market Share by Application (2021-2032) Figure 25. North America Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 26. North America Nifedipine Sales Market Share by Country (2021-2032) Figure 27. U.S. Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 28. Canada Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 29. Mexico Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 30. Europe Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 31. Europe Nifedipine Sales Market Share by Country (2021-2032) Figure 32. Germany Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 33. France Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 34. U.K. Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 35. Italy Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 36. Netherlands Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 37. Asia Pacific Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 38. Asia Pacific Nifedipine Sales Market Share by Country (2021-2032) Figure 39. China Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 40. Japan Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 41. South Korea Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 42. Southeast Asia Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 43. India Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 44. Australia Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 45. South America, Middle East and Africa Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 46. South America, Middle East and Africa Nifedipine Sales Market Share by Country (2021-2032) Figure 47. Brazil Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 48. South Africa Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 49. Saudi Arabia Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 50. Turkey Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 51. Argentina Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 52. UAE Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 53. Egypt Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 54. Chile Nifedipine Sales and Growth Rate (2021-2032) & (tons) Figure 55. Global Nifedipine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Nifedipine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Nifedipine Revenue (2021-2032) & (US$ Million) Figure 58. North America Nifedipine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Nifedipine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Nifedipine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Nifedipine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Nifedipine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Nifedipine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Nifedipine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Nifedipine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Nifedipine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Nifedipine Controlled Release Tablets
  • Nifedipine Extended Action Tablets
Applications
  • Hypertension
  • Heart Disease
  • Other
Companies covered
  • Actavis
  • Bayer
  • Honglin Pharmaceutical
  • Huanghai
  • Pfizer
  • Lifeon Pharmaceutical
  • Teva
  • Simcere
  • Shyndec
  • Yabao
  • ApicHope
  • EASEHEAL Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nifedipine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nifedipine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nifedipine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nifedipine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nifedipine Market Dynamics
  1. 2.1 Nifedipine Industry Trends
  2. 2.2 Nifedipine Industry Drivers
  3. 2.3 Nifedipine Industry Opportunities and Challenges
  4. 2.4 Nifedipine Industry Restraints
3 Nifedipine Market by Manufacturers
  1. 3.1 Global Nifedipine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nifedipine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nifedipine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nifedipine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nifedipine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nifedipine Manufacturers, Product Type & Application
  7. 3.7 Global Nifedipine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nifedipine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nifedipine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nifedipine Tier 1, Tier 2, and Tier 3
4 Nifedipine Market by Type
  1. 4.1 Nifedipine Type Introduction
  2. 4.1.1 Nifedipine Controlled Release Tablets
  3. 4.1.2 Nifedipine Extended Action Tablets
  4. 4.2 Global Nifedipine Sales by Type
  5. 4.2.1 Global Nifedipine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nifedipine Sales by Type (2021-2032)
  7. 4.2.3 Global Nifedipine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Nifedipine Revenue by Type
  9. 4.3.1 Global Nifedipine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nifedipine Revenue by Type (2021-2032)
  11. 4.3.3 Global Nifedipine Revenue Market Share by Type (2021-2032)
5 Nifedipine Market by Application
  1. 5.1 Nifedipine Application Introduction
  2. 5.1.1 Hypertension
  3. 5.1.2 Heart Disease
  4. 5.1.3 Other
  5. 5.2 Global Nifedipine Sales by Application
  6. 5.2.1 Global Nifedipine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nifedipine Sales by Application (2021-2032)
  8. 5.2.3 Global Nifedipine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Nifedipine Revenue by Application
  10. 5.3.1 Global Nifedipine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nifedipine Revenue by Application (2021-2032)
  12. 5.3.3 Global Nifedipine Revenue Market Share by Application (2021-2032)
6 Global Nifedipine Sales by Region
  1. 6.1 Global Nifedipine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nifedipine Sales by Region (2021-2032)
  3. 6.2.1 Global Nifedipine Sales by Region (2021-2026)
  4. 6.2.2 Global Nifedipine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nifedipine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nifedipine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nifedipine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nifedipine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nifedipine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nifedipine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nifedipine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nifedipine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nifedipine Revenue by Region
  1. 7.1 Global Nifedipine Revenue by Region
  2. 7.1.1 Global Nifedipine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nifedipine Revenue by Region (2021-2026)
  4. 7.1.3 Global Nifedipine Revenue by Region (2027-2032)
  5. 7.1.4 Global Nifedipine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nifedipine Revenue (2021-2032)
  8. 7.2.2 North America Nifedipine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nifedipine Revenue (2021-2032)
  11. 7.3.2 Europe Nifedipine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nifedipine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nifedipine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nifedipine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nifedipine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Actavis
  2. 8.1.1 Actavis Company Information
  3. 8.1.2 Actavis Business Overview
  4. 8.1.3 Actavis Nifedipine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Actavis Nifedipine Product Portfolio
  6. 8.1.5 Actavis Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Nifedipine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Nifedipine Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Honglin Pharmaceutical
  14. 8.3.1 Honglin Pharmaceutical Company Information
  15. 8.3.2 Honglin Pharmaceutical Business Overview
  16. 8.3.3 Honglin Pharmaceutical Nifedipine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Honglin Pharmaceutical Nifedipine Product Portfolio
  18. 8.3.5 Honglin Pharmaceutical Recent Developments
  19. 8.4 Huanghai
  20. 8.4.1 Huanghai Company Information
  21. 8.4.2 Huanghai Business Overview
  22. 8.4.3 Huanghai Nifedipine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Huanghai Nifedipine Product Portfolio
  24. 8.4.5 Huanghai Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Nifedipine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Nifedipine Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Lifeon Pharmaceutical
  32. 8.6.1 Lifeon Pharmaceutical Company Information
  33. 8.6.2 Lifeon Pharmaceutical Business Overview
  34. 8.6.3 Lifeon Pharmaceutical Nifedipine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lifeon Pharmaceutical Nifedipine Product Portfolio
  36. 8.6.5 Lifeon Pharmaceutical Recent Developments
  37. 8.7 Teva
  38. 8.7.1 Teva Company Information
  39. 8.7.2 Teva Business Overview
  40. 8.7.3 Teva Nifedipine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Teva Nifedipine Product Portfolio
  42. 8.7.5 Teva Recent Developments
  43. 8.8 Simcere
  44. 8.8.1 Simcere Company Information
  45. 8.8.2 Simcere Business Overview
  46. 8.8.3 Simcere Nifedipine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Simcere Nifedipine Product Portfolio
  48. 8.8.5 Simcere Recent Developments
  49. 8.9 Shyndec
  50. 8.9.1 Shyndec Company Information
  51. 8.9.2 Shyndec Business Overview
  52. 8.9.3 Shyndec Nifedipine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shyndec Nifedipine Product Portfolio
  54. 8.9.5 Shyndec Recent Developments
  55. 8.10 Yabao
  56. 8.10.1 Yabao Company Information
  57. 8.10.2 Yabao Business Overview
  58. 8.10.3 Yabao Nifedipine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yabao Nifedipine Product Portfolio
  60. 8.10.5 Yabao Recent Developments
  61. 8.11 ApicHope
  62. 8.11.1 ApicHope Company Information
  63. 8.11.2 ApicHope Business Overview
  64. 8.11.3 ApicHope Nifedipine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ApicHope Nifedipine Product Portfolio
  66. 8.11.5 ApicHope Recent Developments
  67. 8.12 EASEHEAL Pharmaceutical
  68. 8.12.1 EASEHEAL Pharmaceutical Company Information
  69. 8.12.2 EASEHEAL Pharmaceutical Business Overview
  70. 8.12.3 EASEHEAL Pharmaceutical Nifedipine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 EASEHEAL Pharmaceutical Nifedipine Product Portfolio
  72. 8.12.5 EASEHEAL Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nifedipine Value Chain Analysis
  2. 9.1.1 Nifedipine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nifedipine Production Mode & Process
  6. 9.2 Nifedipine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nifedipine Distributors
  9. 9.2.3 Nifedipine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst